| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2023 ( Subtotal = $407,313 ) |
| 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Biology Research | 000 | 10 | 4/26/2023 | NON-COMPETING CONTINUATION | $407,313 |
|
| Issue Date FY: 2022 ( Subtotal = $407,313 ) |
| 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Biology Research | 000 | 9 | 2/21/2022 | NON-COMPETING CONTINUATION | $391,875 |
| 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Biology Research | 001 | 9 | 4/25/2022 | NON-COMPETING CONTINUATION | $15,438 |
|
| Issue Date FY: 2021 ( Subtotal = $415,625 ) |
| 2021 | 2021 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Biology Research | 000 | 8 | 4/8/2021 | NON-COMPETING CONTINUATION | $415,625 |
|
| Issue Date FY: 2020 ( Subtotal = $415,625 ) |
| 2020 | 2020 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Biology Research | 000 | 7 | 3/24/2020 | NON-COMPETING CONTINUATION | $415,625 |
| 2020 | 2020 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Biology Research | 001 | 7 | 8/13/2020 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $415,605 ) |
| 2019 | 2019 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Biology Research | 001 | 6 | 5/15/2019 | COMPETING CONTINUATION | $415,625 |
| 2019 | 2017 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Biology Research | 000 | 5 | 1/16/2019 | NON-COMPETING CONTINUATION | -$20 |
|
| Issue Date FY: 2017 ( Subtotal = $361,050 ) |
| 2017 | 2017 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Biology Research | 001 | 5 | 5/19/2017 | NON-COMPETING CONTINUATION | $361,050 |
| 2017 | 2015 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Biology Research | 000 | 3 | 11/28/2016 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $361,050 ) |
| 2016 | 2016 | BETH ISRAEL HOSPITAL | 330 BROOKLINE AVENUE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Biology Research | 000 | 4 | 5/12/2016 | EXTENSION WITH OR WITHOUT FUNDS | $361,050 |
|
| Issue Date FY: 2015 ( Subtotal = $361,050 ) |
| 2015 | 2015 | BETH ISRAEL HOSPITAL | 330 BROOKLINE AVENUE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Biology Research | 000 | 3 | 5/11/2015 | NON-COMPETING CONTINUATION | $361,050 |
|
| Issue Date FY: 2014 ( Subtotal = $350,219 ) |
| 2014 | 2014 | BETH ISRAEL HOSPITAL | 330 BROOKLINE AVENUE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Biology Research | 000 | 2 | 6/13/2014 | NON-COMPETING CONTINUATION | $350,219 |
|
| Issue Date FY: 2013 ( Subtotal = $361,050 ) |
| 2013 | 2013 | BETH ISRAEL HOSPITAL | 330 BROOKLINE AVENUE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Biology Research | 000 | 1 | 7/16/2013 | NEW | $361,050 |
|
|